Evidence map›Paper›PMID 29709557›Full record

ReviewGenomics, proteomics & bioinformatics2018

Structural Insights into N

Jinbo Huang, Ping Yin

Open access · goldAbstract readReview
In one paragraph

Review in Genomics, proteomics & bioinformatics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 1 synthesis or guideline pooled it, 101 citations in OpenAlex.

  1. Emerging Roles of mFrontiers in oncology · 2022
    Pooled it
  2. Article
  3. Targeting intracellular mRNA mJournal of advanced research · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. N6-methyladenosine methylation: a novel key to unlocking mental disorders.The international journal of neuropsychopharmacology · 2025
    Review
  10. Article
  11. Review
  12. Epigenetics-targeted drugs: current paradigms and future challenges.Signal transduction and targeted therapy · 2024
    Review
  13. Article
  14. Article
  15. Reading the mCell & bioscience · 2024
    Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Role of NOncology reports · 2024
    Review

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jinbo HuangNational Key Laboratory of Crop Genetic Improvement and National Center of Plant Gene Research, Huazhong Agricultural University, Wuhan 430070, China.
Ping YinNational Key Laboratory of Crop Genetic Improvement and National Center of Plant Gene Research, Huazhong Agricultural University, Wuhan 430070, China. Electronic address: yinping@mail.hzau.edu.cn.
Huazhong Agricultural University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

More than 100 types of chemical modifications in RNA have been well documented. Recently, several modifications, such as N

Indexed as

AdenosineAnimalsGene Expression RegulationHumansMethyltransferasesRNA-Binding ProteinsRNA, MessengerRNA, UntranslatedTranscriptomeAdenosineMethyltransferasesN-methyladenosineRNA-Binding ProteinsRNA, MessengerRNA, UntranslatedEpitranscriptomicsEraserM(6)A modificationReaderWriter

Identifiers

PMID29709557
PMCPMC6112310
OpenAlexW2799346732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.